Related Experiment Video
Updated: May 17, 2026
Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
Published on: March 17, 2016
Structurally similar estradiol analogs uniquely alter the regulation of intracellular signaling pathways
James G Yarger1, Robert E Babine, Michael Bittner
1ENDECE, LLC, Mequon, Wisconsin 53092, USA. james.yarger@endece.com
Abstract:
Ligand structure can affect the activation of nuclear receptors, such as estrogen receptors (ERs), and their control of signaling pathways for cellular responses including death and differentiation. We hypothesized that distinct biological functions of similar estradiol (E(2)) analogs could be identified by integrating gene expression patterns obtained from human tumor cell lines with receptor binding and functional data for the purpose of developing compounds for treatment of a variety of diseases. We compared the estrogen receptor subtype selectivity and impact on signaling pathways for three distinct, but structurally similar, analogs of E(2). Modifications in the core structure of E(2) led to pronounced changes in subtype selectivity for estrogen receptors, ER-α or ER-β, along with varying degrees of ER dimerization and activation. While all three E(2) analogs are predominantly ER-β agonists, the cell growth inhibitory activity commonly associated with this class of compounds was detected for only two of the analogs and might be explained by a ligand-specific pattern of gene transcription. Microarray studies using three different human tumor cell lines demonstrated that the analogs distinctly affect the transcription of genes in signaling pathways for chromosome replication, cell death, and oligodendrocyte progenitor cell differentiation. That the E(2) analogs could lower tumor cell viability and stimulate neuronal differentiation confirmed that gene expression data could accurately distinguish biological activity of the E(2) analogs. The findings reported here confirm that cellular responses can be regulated by making key structural alterations to the core structure of endogenous ER ligands.
Insights
Structural changes in estradiol analogs alter estrogen receptor (ER) activity, influencing gene expression and cell responses. This research distinguishes biological functions of ER ligands for potential disease treatments.
Area of Science:
- Molecular Endocrinology
- Cancer Biology
- Neuroscience
Background:
- Nuclear receptors, like estrogen receptors (ERs), regulate cellular responses through signaling pathways.
- Estradiol (E(2)) analogs' structural modifications can influence ER subtype selectivity and downstream effects.
- Understanding these structure-activity relationships is crucial for developing targeted therapeutics.
Purpose of the Study:
- To investigate how structural variations in estradiol analogs affect estrogen receptor subtype selectivity (ER-α vs. ER-β).
- To identify distinct biological functions and gene expression patterns induced by structurally similar E(2) analogs.
- To explore the potential of these analogs in modulating cancer cell viability and neuronal differentiation for therapeutic applications.
Main Methods:
- Comparative analysis of three distinct, structurally similar estradiol analogs.
- Assessment of estrogen receptor subtype selectivity, dimerization, and activation.
- Gene expression profiling using microarrays in human tumor cell lines.
- Evaluation of cell growth inhibitory activity and neuronal differentiation potential.
Main Results:
- Estradiol analogs exhibited varying ER subtype selectivity, predominantly acting as ER-β agonists.
- Cell growth inhibitory effects were observed for only two of the three analogs, linked to specific gene transcription patterns.
- Distinct effects on gene transcription pathways involved in chromosome replication, cell death, and oligodendrocyte progenitor cell differentiation were identified.
- E(2) analogs demonstrated the ability to reduce tumor cell viability and promote neuronal differentiation.
Conclusions:
- Gene expression data accurately distinguishes the biological activities of structurally similar E(2) analogs.
- Key structural alterations in endogenous ER ligands can precisely regulate cellular responses.
- These findings support the development of novel compounds targeting ER pathways for disease treatment.
More Related Videos
06:18An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
09:07Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay
Published on: December 19, 2018
Related Concept Videos
01:31Internal Receptors
01:08Chemical Signaling in the Endocrine System
Lipid-soluble hormones, such as steroid hormones, demonstrate an intracellular action. These hormones traverse cell membranes due to their lipid nature. Once inside the target cell, they...
01:22Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
01:26Signal Transduction: Overview
Typically, signal transduction involves three...
01:07Types of Receptors: Internal Receptors
Similar to membrane-bound receptors, the binding of a ligand to the intracellular receptor of causes a conformational change in the...
01:31Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes: